CRISPR Therapeutics AG
$57.72
-1.65 (-2.78%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +19.2%
- 3 Months
- +2.7%
- YTD
- +10.1%
- 1 Year
- +7.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 60.0%
- Largest decline max drawdown, since Aug 2025
- -42.3%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.42
Own CRSP?
See how CRSP contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.